Need Help?

Cabozantinib Response in ETV6-NTRK3 G623R Positive Carcinoma HIPO-021

We report a case of marked response to cabozantinib in a secondary entrectinib-resistant tumor harboring the ETV6-NTRK3 fusion with a G623R solvent-front mutation.

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID Description Technology Samples
EGAD00001006243 HiSeq X Ten 2
Publications Citations
Response to Cabozantinib Following Acquired Entrectinib Resistance in a Patient With ETV6-NTRK3 Fusion-Positive Carcinoma Harboring the NTRK3G623R Solvent-Front Mutation.
JCO Precis Oncol 5: 2021 PO.20.00278
3